Dipeptidyl peptidase-4 inhibitor might exacerbate Graves' disease : A multicenter observational case-control study

MLA

Sekizaki, Tomonori, et al. Dipeptidyl Peptidase-4 Inhibitor Might Exacerbate Graves’ Disease : A Multicenter Observational Case-Control Study. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1274193387&authtype=sso&custid=ns315887.

APA

Sekizaki, T., Kameda, H., Nomoto, H., Cho, K. Y., Nakamura, A., Takahashi, K., Miyoshi, A., Wada, N., Takeuchi, J., Nagai, S., Miyoshi, H., & Atsumi, T. (2021). Dipeptidyl peptidase-4 inhibitor might exacerbate Graves’ disease : A multicenter observational case-control study.

Chicago

Sekizaki, Tomonori, Hiraku Kameda, Hiroshi Nomoto, Kyu Yong Cho, Akinobu Nakamura, Kiyohiko Takahashi, Arina Miyoshi, et al. 2021. “Dipeptidyl Peptidase-4 Inhibitor Might Exacerbate Graves’ Disease : A Multicenter Observational Case-Control Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1274193387&authtype=sso&custid=ns315887.